Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Medtronic has a broad portfolio of DBS systems technology and features that can make a difference for you now and in the future. Once you’ve made the decision to get DBS Therapy, you’ll work with your doctor to select the DBS device that’s right for you.
As a global leader in medical technology, we continually seek ways to improve the lives of people. DBS development started in 1987 and Medtronic has been leading the way ever since. Medtronic DBS Therapy systems are rigorously tested and FDA approved.
With a complete Medtronic system — lead(s), extension(s), and neurostimulator — you get:
Use our online directory to search for Parkinson's specialists by ZIP code. Find a doctor who will understand your needs and treatment options, and call for an appointment.
Get the information and support you need to make a confident decision about DBS therapy.
Signal may not be present or measurable in all patients. Clinical benefits of brain sensing have not been established.
For median energy use in DBS for patients with Parkinson's disease, with moderate (up to two months per year) BrainSense™ technology usage.
Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If these conditions are not met, there is a significant risk of tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury, including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions: http://professional.medtronic.com/mri.
Activa™ RC devices eligible for the service life extension and the supplemental limited warranty are those devices sold in the US that have been successfully interrogated with the Medtronic Activa™ Clinician Programmer prior to reaching End of Service (EOS). For additional information, contact email@example.com
Falowski, S, Safriel Y, Ryan, M et al. The Rate of Magnetic Resonance Imaging in Patients with Deep Brain Stimulation. Stereotactic and Functional Neurosurgery. 2016; 94:147–153.